✦ LIBER ✦

Angiogenic cell therapy for hepatic fibrosis

✍ Scribed by Takato Ueno; Toru Nakamura; Takuji Torimura; Michio Sata

Publisher: Springer
Year: 2006
Tongue: English
Weight: 370 KB
Volume: 39
Category: Article
ISSN: 0918-4287
DOI: 10.1007/s00795-006-0311-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic fibrosis—Current concepts of pat

Hepatic fibrosis—Current concepts of pathogenesis and therapy

✍ Högemann, Bernhard ;Domschke, Wolfram 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 891 KB

Gene therapy for hepatic fibrosis—bringi

Gene therapy for hepatic fibrosis—bringing treatment into the new millennium

✍ Don C. Rockey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

We eliminated type beta transforming growth factor (TGF-beta) signaling by adenovirus-mediated local expression of a dominant-negative type II TGF-beta receptor (AdCATbeta-TR) in the liver of rats treated with dimethylnitrosamine, a model of persistent liver fibrosis. In rats that received a single

Therapeutic strategies for hepatic fibro

Therapeutic strategies for hepatic fibrosis

✍ Mario Chojkier; David A. Brenner 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 911 KB

The mechanisms responsible for the increased hepatic connective tissue deposition in cirrhosis remain unknown; and there is no established therapy for hepatic fibrosis. In this issue of Hepatology, Ruwart et al. (1) report that 16,16-dimethyl prostaglandin E2 (DMPG) inhibits hepatic collagen deposit

Combining angiogenic gene and stem cell

Combining angiogenic gene and stem cell therapies for myocardial infarction

✍ Jennifer Pons; Yu Huang; Junya Takagawa; Janice Arakawa-Hoyt; Jianqin Ye; Willia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

## Abstract ## Background Transplantation of stem cells from various sources into infarcted hearts has the potential to promote myocardial regeneration. However, the regenerative capacity is limited partly as a result of the low survival rate of the transplanted cells in the ischemic myocardium. I

Progressive fibrosis during corticostero

Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis

✍ Albert J. Czaja; Herschel A. Carpenter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Hepatic fibrosis and cirrhosis are possible consequences of corticosteroid-treated autoimmune hepatitis. Our aims were to determine the frequency of progressive fibrosis and the factors associated with this progression. Two hundred seventy-seven liver tissue specimens that had been obtained from 73

Molecular mechanisms of hepatic fibrosis

Molecular mechanisms of hepatic fibrosis and principles of therapy

✍ Scott L. Friedman 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 746 KB